Senate Aging Committee Hears Proposals On How To Lower Cost Of RA Biologics

Senate Aging Committee Chair Susan Collins (R-ME) raised concerns during a committee hearing Wednesday (Feb. 7) over price hikes associated with two of the world’s best-selling drugs, both of which treat Rheumatoid Arthritis (RA), as well as the patent thicket that has kept lower-price competitors off the market. Collins also promised to raise with CMS her concerns with its existing policy that incentivizes patients that are steady on a self-administered drug when covered by private insurance to switch to a...